Literature DB >> 22698582

DRD2/ANKK1 TaqIA and SLC6A3 VNTR polymorphisms in alcohol dependence: association and gene-gene interaction study in a population of Central Italy.

Fiorenzo Mignini1, Valerio Napolioni, Claudia Codazzo, Francesco M Carpi, Mario Vitali, Marina Romeo, Mauro Ceccanti.   

Abstract

Dopamine is a neurotransmitter whose functions are mediated by five receptors expressed in several organs and tissues. Dopaminergic system dysfunctions are involved in the etiology or treatment of several pathological conditions, including drug addiction. Alcohol dependence (AD) is a widespread psychiatric disorder, affecting 5.4% of the general population lifetime. Family and twins studies support the role of a genetic component in AD. Since dopamine neurotransmission has been shown to be involved in drug reward, related genes are plausible candidates for susceptibility to AD. Here, we evaluated both the DRD2/ANKK1 TaqIA (rs1800497) and SLC6A3 40 bp-VNTR SNP and gene-gene interaction analysis in AD patients from a population of Central Italy. The study design was a case-control. In total, 280 alcoholic subjects (213 men and 67 woman) and 280 age- and sex-matched control subjects were recruited for this study. Case subjects met the DSM-IV criteria for AD and they are free from any psychiatric co-morbidities. Controls were subjects who had non-alcohol problem either never drank; those who have smoked at least one pack of cigarettes per day for at least 1 year were excluded. Genotyping was performed by allele-specific PCR and RFLP-PCR. SLC6A3 40 bp 3'UTR-VNTR displays no association with AD. DRD2/ANKK1 TaqIA genotype distribution is significantly associated to AD (O.R.=1.551, p=0.023), with A1* allele displaying an O.R.=1.403 (p=0.029). Gene-gene interaction analysis using three-way contingency table analysis by a log-linear model yielded no significant result. Our study in a population of Central Italy extends and confirms previous results and, for the first time, tested the gene-gene interaction between SLC6A3 and DRD2 in AD.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22698582     DOI: 10.1016/j.neulet.2012.06.008

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

Review 1.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

Review 2.  Alcohol Use Disorder: Neurobiology and Therapeutics.

Authors:  Waisley Yang; Rohit Singla; Oshin Maheshwari; Christine J Fontaine; Joana Gil-Mohapel
Journal:  Biomedicines       Date:  2022-05-21

3.  Meta-Analysis Reveals Significant Association of the 3'-UTR VNTR in SLC6A3 with Alcohol Dependence.

Authors:  Yunlong Ma; Rongli Fan; Ming D Li
Journal:  Alcohol Clin Exp Res       Date:  2016-05-24       Impact factor: 3.455

4.  Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction.

Authors:  Cielito C Reyes-Gibby; Christine Yuan; Jian Wang; Sai-Ching J Yeung; Sanjay Shete
Journal:  BMC Syst Biol       Date:  2015-06-05

5.  Assessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders: A Systematic Review and Meta-analysis.

Authors:  Yonwoo Jung; Rachel A Montel; Pei-Hong Shen; Deborah C Mash; David Goldman
Journal:  JAMA Netw Open       Date:  2019-11-01

6.  Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention.

Authors:  Christian L Roth; Anke Hinney; Ellen A Schur; Clinton T Elfers; Thomas Reinehr
Journal:  BMC Pediatr       Date:  2013-11-27       Impact factor: 2.125

7.  Associations Between the Dopamine D4 Receptor and DAT1 Dopamine Transporter Genes Polymorphisms and Personality Traits in Addicted Patients.

Authors:  Jolanta Chmielowiec; Krzysztof Chmielowiec; Aleksandra Suchanecka; Grzegorz Trybek; Bożena Mroczek; Iwona Małecka; Anna Grzywacz
Journal:  Int J Environ Res Public Health       Date:  2018-09-21       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.